Format
Sort by

Send to

Choose Destination

Search results

Items: 9

1.

Balancing Inflammation: The Link between Th17 and Regulatory T Cells.

Diller ML, Kudchadkar RR, Delman KA, Lawson DH, Ford ML.

Mediators Inflamm. 2016;2016:6309219. doi: 10.1155/2016/6309219. Epub 2016 Jun 19. Review.

2.

Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.

Oliver DE, Patel KR, Switchenko J, Parker D, Lawson DH, Delman KA, Kudchadkar RR, Khan MK.

Melanoma Res. 2016 Feb;26(1):35-41. doi: 10.1097/CMR.0000000000000201.

3.

Genomic Classification of Cutaneous Melanoma.

Cancer Genome Atlas Network.

Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.

4.

The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist?

Fisher SB, Baxter KJ, Staley CA 3rd, Fisher KE, Monson DK, Murray DR, Oskouei SV, Weiss SW, Kooby DA, Maithel SK, Delman KA.

J Am Coll Surg. 2013 Nov;217(5):881-8. doi: 10.1016/j.jamcollsurg.2013.06.003. Epub 2013 Sep 25.

5.

Pediatric melanoma: analysis of an international registry.

Averbook BJ, Lee SJ, Delman KA, Gow KW, Zager JS, Sondak VK, Messina JL, Sabel MS, Pittelkow MR, Ecker PM, Markovic SN, Swetter SM, Leachman SA, Testori A, Curiel-Lewandrowski C, Go RS, Jukic DM, Kirkwood JM.

Cancer. 2013 Nov 15;119(22):4012-9. doi: 10.1002/cncr.28289. Epub 2013 Sep 10.

6.

CD45/CD8 Myeloid Histioid Antigen and Plasma Cell Antibody Immune Response in a Case of Malignant Melanoma.

Abreu-Velez AM, Howard MS, Pereyo NY, Delman KA, Mihm MC, Rizzo M.

N Am J Med Sci. 2012 Oct;4(10):507-9. doi: 10.4103/1947-2714.102006.

7.

Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.

Turaga KK, Beasley GM, Kane JM 3rd, Delman KA, Grobmyer SR, Gonzalez RJ, Letson GD, Cheong D, Tyler DS, Zager JS.

Arch Surg. 2011 Jul;146(7):870-5. doi: 10.1001/archsurg.2011.139.

8.

Management of regional lymph node basins in melanoma.

Love TP, Delman KA.

Ochsner J. 2010 Summer;10(2):99-107.

9.

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.

Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF, Halterman MW, Federoff HJ, Fong Y.

Ann Surg. 2002 Sep;236(3):337-42; discussion 342-3.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk